Yes sir RVXOldtimer ... and the further RVX gets "down the road on their own", the more the risk lessens for a buyer, and the price goes up. So there is leverage. Assuming the science keeps moving in the right direction, toward approvals/commercialization gradually/eventually, and partnering funds can keep it floating toward those goals in the meantime. 

Cognition data is great. 

FDA letter could be greater, in the short term.